Clinical
Concept Realisation's Nasser Massoud says GCC digital health success depends on patients trusting technology, regulators supporting innovation sans safety risks and insurers paying providers fairly for telehealth services.
Michael Abrams of Numerof & Associates explains the need for the U.S. Food and Drug Administration to move faster on healthcare artificial intelligence governance, and why its drug development validation process is a good model.
Amy Tucker of Advocate Health's Sanger Heart & Vascular Institute explains what it takes to move to a scalable platform that improves clinical administration and patient care.
Experts advise healthcare organizations to ask: "Who will be accountable for decisions influenced by artificial intelligence – the clinician, department, vendor or hospital? And what will be needed to defend AI-influenced decisions?"
Its president, Dr. Baligh Yehia, says the Philadelphia health system has committed to returning 10 million hours back to patient care over the next three years using AI.
Julia Zarb, principal and founder of Blue x Blue, discusses her upcoming HIMSS26 talk, exploring "human in the loop" AI practices and workflows that support human decision-making.
The popular AI tool for healthcare professionals may also soon come to public outpatient clinics in New Zealand.
Gold Coast Health is the first in Queensland to pilot this concept, initially supporting collaboration between local GPs and developmental paediatricians.
Elation Health and HealthEx announce they are integrating Anthropic's Claude artificial intelligence to better synthesize health data for doctors and patients.
Mass General Brigham plans to make online primary care access available to all insured Massachusetts and New Hampshire residents. The primary care access situation in the Bay State has been called "dire."